Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Cash from Operations (2021 - 2026)

HeartSciences' Cash from Operations history spans 6 years, with the latest figure at 1462526.0 for Q1 2026.

  • For Q1 2026, Cash from Operations rose 9.73% year-over-year to 1462526.0; the TTM value through Jan 2026 reached 7340799.0, up 0.79%, while the annual FY2025 figure was 7412994.0, 22.12% down from the prior year.
  • Cash from Operations reached 1462526.0 in Q1 2026 per HSCS's latest filing, up from 2334266.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 966278.0 in Q1 2022 to a low of 2334266.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 1597971.47, with a median of 1590640.0 recorded in 2025.
  • Peak YoY movement for Cash from Operations: plummeted 152.51% in 2022, then rose 22.89% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 1080141.0 in 2022, then grew by 8.51% to 988187.0 in 2023, then tumbled by 120.97% to 2183550.0 in 2024, then fell by 6.9% to 2334266.0 in 2025, then skyrocketed by 37.35% to 1462526.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Cash from Operations are 1462526.0 (Q1 2026), 2334266.0 (Q4 2025), and 1953367.0 (Q3 2025).